For more than 25 years, Biomedical Development Corporation has been bringing commercially-viable products to market by linking promising technologies with vital sources of research funding.
Principal Investigator(s)
Dr. Charles L. Bowden, M.D.
Susan L. McElroy, M.D.
Rif S. El-Mallakh, M.D.
Funded by
National Institute of Mental Health (NIMH)
The goal of this project is to complete the development of a patient-centered software system and mobile app to assist in managing bipolar disorder. The clinical trial (n=120) is a randomized 52 week, blinded rater comparison of KIOS Bipolar to a popular mood charting program.